Jie Liang

Jie Liang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
He ZhouHe Zhou
He Zhou
ZFZhenzhen Fan
Zhenzhen Fan
YDYu Da
Yu Da
XLXiaoning Liu
Xiaoning Liu
CWChen Wang
Chen Wang
JLJie Liang
Jie Liang
Background: Iron deficiency anemia (IDA) is a common type of anemia in children and pregnant women. The effects of iron deficiency on gut microbiota and metabolic profiles are not fully understood. Methods: Mendelian randomization (MR) analysis was conducted to explore associations among IDA, gut microbiota, and metabolites. MR analysis was conducted using computational methods, utilizing human genetic data. Data were obtained from genome-wide association studies (GWAS), with inverse-variance-weighted (IVW) as the primary method. Animal models evaluated the effects of IDA on gut microbiota and metabolic profiles. Results: IVW analysis revealed significant associations between gut microbial taxa and IDA. The genus Desulfovibrio was protective (OR = 0.85, 95% CI: 0.77–0.93, p = 0.001), while Actinomyces (OR = 1.12, 95% CI: 1.01–1.23, p = 0.025) and family XIII (OR = 1.16, 95% CI: 1.01–1.32, p = 0.035) increased IDA risk. Glycine was protective (OR = 0.95, 95% CI: 0.91–0.99, p = 0.011), whereas medium low density lipoprotein (LDL) phospholipids increased risk (OR = 1.07, 95% CI: 1.00–1.15, p = 0.040). Animal models confirmed reduced Desulfovibrio, increased Actinomyces, and altered metabolites, including amino acids and phospholipids. Conclusions: IDA significantly impacts gut microbiota and metabolic profiles, offering insights for therapeutic strategies targeting microbiota and metabolism.

4 November 2025 in Phytomedicine
Verified
Journal Article
Closed access
JLJunchao Lin
Junchao Lin
CWChen Wang
Chen Wang
GYGang Yang
Gang Yang
YLYutong Liu
Yutong Liu
YDYu Da
Yu Da
JLJie Liang
Jie Liang

17 April 2026 in Metabolism
Verified
Journal Article
Closed access
JLJunchao Lin
Junchao Lin
TWTong Wu
Tong Wu
CWChen Wang
Chen Wang
WZWei Zhou
Wei Zhou
YLYutong Liu
Yutong Liu
JLJie Liang
Jie Liang

23 May 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
RLRuixia Li
Ruixia Li
XLXiaofei Li
Xiaofei Li
HZHe Zhou
He Zhou
YSYanting Shi
Yanting Shi
FWFang Wang
Fang Wang
JLJie Liang
Jie Liang
Objective: Behçet’s Disease (BD) is an intractable systemic vasculitis. When accompanied by intestinal symptoms, the prognosis is usually poor. 5-Aminosalicylic acid (5-ASA), corticosteroids, immunosuppressive drugs, and anti-tumor necrosis factor-α (anti-TNF-α) biologics are standard therapies to induce or maintain remission for intestinal BD. However, they might not be effective in refractory cases. Safety should also be considered when patients have an oncology history. Regarding the pathogenesis of intestinal BD and the specific targeting effect of vedolizumab (VDZ) on the inflammation of the ileum tract, previous case reports suggested that VDZ might be a potential treatment for refractory intestinal BD.Methods: We report a 50-year-old woman patient with intestinal BD who had oral and genital ulcers, joint pain, and intestinal involvement for about 20 years. The patient responds well to anti-TNF-α biologics but not to conventional drugs. However, biologics treatment was discontinued due to the occurrence of colon cancer.Results: VDZ was intravenously administered at a dose of 300 mg at 0, 2, and 6 weeks and then every eight weeks. At the 6-month follow-up, the patient reported significant improvement in abdominal pain and arthralgia. We observed complete healing of intestinal mucosal ulcers under endoscopy. However, her oral and vulvar ulcers remained unresolved, which disappeared after adding thalidomide.Conclusion: VDZ may be a safe and effective option for refractory intestinal BD patients who do not respond well to conventional treatments, especially those with an oncology history.

8 March 2021 in Gut
Verified
Journal Article
Open access
PDF file
He ZhouHe Zhou
He Zhou
FCFenrong Chen
Fenrong Chen
JWJiayao Wang
Jiayao Wang
XLXin Liu
Xin Liu
JLJie Liang
Jie Liang
A 45-year-old man developed multiple papules on the abdomen (with sizes of about 2–15 mm) for 9 months (figure 1), intermittent black stool and abdominal pain for 5 months. Colonoscopy revealed chronic inflammation of the colorectal mucosa (pathological results indicated active inflammation of the mucosa and Epstein-Barr virus positive) (figure 2). CT enterography examinations revealed segmental ileal stenosis in the right lower abdomen. The abdominal pain worsened 3 days before admission. Laboratory examinations during hospitalisation showed that C reactive protein was 31.53 ng/L; fibrinogen was 5.77 g/L and D-dimer was 1308 ng/mL, respectively. On the day of hospitalisation, the patient had sudden aggravation of abdominal pain without flatus and defecation. Physical examination showed abdominal tenderness, rebound pain and muscle tension. Abdominal X-ray indicated intestinal obstruction. Emergency laparotomy was performed. During the operation, a large number of gas, yellow faecal water and abscesses were seen. Multiple ischaemia and perforations in the small intestine (seven places) were detected.